Máj- és epeúti rák: vizsgálatok itt: Belgium
29 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseNot yet taking people in BelgiumINPACT: Implementation of Nutritional Support and Physical Activity During Cancer Treatment
- Where
- Kortrijk
- Életkor
- 18 év and over
- People
- 103
- Run by
- General Hospital Groeninge
See details and how to joinNCT07929597 - No phaseTaking peopleA Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
- Where
- Auderghem, Ghent, Haine-Saint-Paul, Liège, Merksem, Mont-godinne
- Életkor
- 18 év and over
- People
- 700 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07284121 - No phaseTaking peopleObservational Study Protocol: LIVER-R
- Where
- Bonheiden, Brussels, Edegem, Leuven, Liège, Stene
- Életkor
- 18 év to 130 év
- People
- 4000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06252753 - 3. fázisTaking peopleEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Bonheiden, Edegem, Leuven
- Életkor
- 18 év and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - 1/2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Charleroi, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - 1. fázisTaking peopleA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
- Where
- Edegem, Kortrijk, Leuven, Sint-Lambrechts-Woluwe
- Életkor
- 18 év and over
- People
- 148 worldwide
- Run by
- Bayer
See details and how to joinNCT06764316 · EU 2024-516615-25-00 - 3. fázisTaking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Anderlecht, Edegem, Gent, Leuven, Liège, Roeselare
- Életkor
- 18 év to 99 év
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - No phaseTaking peopleSTRATHEP: AI-Driven Treatment Stratification for Advanced Hepatocellular Carcinoma
- Where
- Anderlecht, Bonheiden, Bruges, Edegem, Leuven
- Életkor
- 18 év and over
- People
- 280
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07863258 - 3. fázisTaking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Leuven
- Életkor
- 18 év and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00 - 1. fázisTaking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Kortrijk
- Életkor
- 18 év and over
- People
- 1394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - 2. fázisTaking peopleF-18 PSMA-11 PET for Imaging and Staging of Hepatocellular carcinoma with Evaluation of Survival
- Where
- Gent
- Életkor
- 18 év and over
- People
- 32
- Run by
- Universitair Ziekenhuis Gent
See details and how to join2023-508709-26-00 · EU 2023-508709-26-00 - 3. fázisTaking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Anderlecht, Edegem, Leuven, Liège, Roeselare
- Életkor
- 18 év and over
- People
- 1100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - 3. fázisTaking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Edegem, Gent, Leuven
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00 - 1. fázisTaking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Anderlecht
- Életkor
- 18 év and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleDRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- Where
- Anderlecht, Edegem, Ghent, Liège
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT07717437 - No phaseTaking peopleImproving the Use of Immunotherapy to Treat Liver Cancer
- Where
- Antwerp, Hasselt, Kortrijk, Roeselare
- Életkor
- 18 év and over
- People
- 300
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07623265 - 3. fázisTaking peoplePersonalized Medicine for Advanced Biliary Cancer Patients
- Where
- Brussels, Edegem, Leuven
- Életkor
- 18 év and over
- People
- 800 worldwide
- Run by
- UNICANCER
See details and how to joinNCT05615818 · EU 2022-502403-30-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleAn Innovative CFD-based Dosimetry and Pre-treatment Planning Platform to Support Personalized Transarterial Therapies for Liver Cancer
- Where
- Ghent
- Életkor
- 18 év and over
- People
- 80
- Run by
- University Hospital, Ghent
See details and how to joinNCT07315633 - 4. fázisTaking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Leuven, Woluwe-Saint-Lambert
- Életkor
- 18 év and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseTaking peopleStereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
- Where
- Brussels, Wilrijk
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Erasmus Medical Center
See details and how to joinNCT06493734 - 3. fázisTaking peopleSystemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
- Where
- Bruxelles
- Életkor
- 18 év and over
- People
- 348 worldwide
- Run by
- Federation Francophone de Cancerologie Digestive
See details and how to joinNCT02885753 · EU 2024-518553-41-00 - No phaseCsak meghívásosInternational Registry of Congenital Portosystemic Shunt (IRCPSS)
- Where
- Brussels
- Életkor
- 1 nap and over
- People
- 500 worldwide
- Run by
- Prof. Valérie Mc Lin
See details and how to joinNCT06041906 - No phaseTaking peopleThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Antwerp, Brussels, Ghent, Hasselt, Jette, Kortrijk, Liège, Yvoir
- Életkor
- 18 év and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - No phaseTaking peopleHolmium-166 Transarterial Radioembolization for the Treatment of Hepatocellular Carcinoma
- Where
- Brussels
- Életkor
- 18 év and over
- People
- 100
- Run by
- Universitair Ziekenhuis Brussel
See details and how to joinNCT06873269